Estrella Immunopharma, Inc. (ESLA)

Nasdaq · Biological Products, (No Diagnostic Substances)

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2025-10-07Xu JiandongofficerP1,0001.33$1,330
2025-09-22Xu JiandongofficerP1,0001.16$1,160
2025-09-11Xu JiandongofficerP1001.04$104

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings